Enliven Therapeutics Inc (ELVN)
EBITDA Growth
-28.61%
Quarterly · Period ending:
ELVN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-28.61%period ending
Latest reported-28.61%period ending
ELVN Quarterly EBITDA YoY % (-71.46% → -28.61%)
Year-over-year change
High-resolution chart · PNG
ELVN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -28.6054% | |
| 17.0601% | |
| -28.2294% | |
| 12.9572% | |
| -28.5845% | |
| -25.6454% | |
| -19.7388% | |
| -11.5268% | |
| -17.9792% | |
| -54.5951% | |
| -103.3734% | |
| -97.1698% | |
| -88.3784% | |
| -69.8378% | |
| -13.4825% | |
| 22.9685% | |
| 32.7269% | |
| 15.6568% | |
| 27.2814% | |
| -9.8806% | |
| -29.05% | |
| -42.289% | |
| -59.1003% | |
| -87.4509% | |
| -88.6048% | |
| -71.4592% |